114 related articles for article (PubMed ID: 1911231)
1. Report of BACR workshop on monoclonal antibodies in breast and ovarian cancer, Brasenose College, Oxford March 17-19th 1991.
Leonard RC; Fisken J; Roulston JE
Br J Cancer; 1991 Oct; 64(4):796-7. PubMed ID: 1911231
[No Abstract] [Full Text] [Related]
2. [CA-12 tumor marker values in serum following radioimmuno-scintigraphy].
Barrada M; Pateisky N; Schatten C; Philipp K; Sevelda P; Vavra N
Gynakol Rundsch; 1990; 30 Suppl 1():72-3. PubMed ID: 2079306
[No Abstract] [Full Text] [Related]
3. Management of patients with ovarian cancer using monoclonal antibodies.
Lastoria S; Panza N; Esposito G; Vergara E; Castelli L; Caracò C; Battista C; Pacilio G; Salvatore M
Biomed Pharmacother; 1992; 46(10):453-63. PubMed ID: 1306360
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer screening.
Kurjak A; Predanic M
Curr Opin Obstet Gynecol; 1994 Feb; 6(1):67-74. PubMed ID: 8180353
[TBL] [Abstract][Full Text] [Related]
5. [CA125 and radioimmunoimaging in monitoring of epithelial ovarian carcinoma].
Yu Q; Lian LJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Jul; 26(4):235-8, 252. PubMed ID: 1914661
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma.
Bast RC; Knapp RC
Important Adv Oncol; 1987; ():39-53. PubMed ID: 3331386
[No Abstract] [Full Text] [Related]
7. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization.
Del Vecchio S; Camera L; Petrillo A; Esposito G; Frasci G; Iaffaioli RV; Bianco AR; Salvatore M
Int J Rad Appl Instrum B; 1991; 18(1):85-7. PubMed ID: 2010311
[TBL] [Abstract][Full Text] [Related]
8. Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
Br J Cancer; 1992 Nov; 66(5):984-5. PubMed ID: 1419648
[No Abstract] [Full Text] [Related]
9. Screening for ovarian cancer. Multiple markers may outperform CA 125 alone.
Bast R; Woolas R
BMJ; 1993 Jun; 306(6893):1684-5. PubMed ID: 8324445
[No Abstract] [Full Text] [Related]
10. Soluble IL-2 alpha and ovarian cancer.
Barton DP
Br J Cancer; 1994 Mar; 69(3):622-3. PubMed ID: 8123502
[No Abstract] [Full Text] [Related]
11. Immunodiagnosis of ovarian tumors.
Jacobs I; Bast RC
Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
[No Abstract] [Full Text] [Related]
12. [REGAJ diagnosis of recurrence of ovarian cancer].
Paterok EM; Jäger W; Feistel H; Lang N; Wolf F
Gynakol Rundsch; 1989; 29 Suppl 2():360-3. PubMed ID: 2613050
[No Abstract] [Full Text] [Related]
13. Correlation between breast cancer mucin (BCM) and CA 125 serum levels in patients with active ovarian tumors.
Roiz C; Allende T; Fernández-García J; Vivanco J; Bianco A; Ruibal A
Int J Biol Markers; 1990; 5(4):207. PubMed ID: 2093735
[No Abstract] [Full Text] [Related]
14. Monoclonal antibodies in breast and ovarian cancer. Proceedings of the British Association for Cancer Research Workshop, Oxford, 17-19 March, 1991.
Dis Markers; 1991; 9(3-4):125-238. PubMed ID: 1687521
[No Abstract] [Full Text] [Related]
15. Genetic risk and screening techniques for epithelial ovarian cancer. ACOG Committee Opinion: Committee on Gynecologic Practice. Number 117--December 1992.
Int J Gynaecol Obstet; 1993 Jun; 41(3):321-3. PubMed ID: 8102999
[No Abstract] [Full Text] [Related]
16. Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.
Ugrinska A; Bombardieri E; Stokkel MP; Crippa F; Pauwels EK
Q J Nucl Med; 2002 Jun; 46(2):88-104. PubMed ID: 12114872
[TBL] [Abstract][Full Text] [Related]
17. The reassessment of ovarian cancer in complete clinical remission: what are our goals?
Clarke-Pearson DL
Gynecol Oncol; 1994 Feb; 52(2):151-3. PubMed ID: 8314131
[No Abstract] [Full Text] [Related]
18. Serum levels of tumor markers and presence of human antimouse antibodies: implications for diagnosis and treatment with radiolabeled monoclonal antibodies.
Bouvier JF; Pernod J; Rivoire M; Maiassi N
Cancer Detect Prev; 1988; 13(3-4):251-62. PubMed ID: 2468412
[TBL] [Abstract][Full Text] [Related]
19. CA-125 as a screening test for ovarian cancer.
Gocze PM; Freeman DA
JAMA; 1993 Jun 23-30; 269(24):3106-7. PubMed ID: 8505808
[No Abstract] [Full Text] [Related]
20. Specificity of a tumor marker (CA54/61) and its individual epitopes recognized by monoclonal antibodies, MA54 and MA61, in human tumor patients.
Mochizuki H; Nagoya K; Yamauchi T; Takao Y; Masuko H; Sato H; Sasaki H; Itoh K; Tsukazaki K; Udagawa Y
J Clin Lab Anal; 1992; 6(4):225-31. PubMed ID: 1383482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
